10 Great Dividend Stocks For The Next 10 Years

09:00am, Saturday, 17'th Aug 2024
The focus of this article is to provide a select list of 10 dividend stocks that, in our view, are currently undervalued and should provide an average of 4.5% plus yield for the foreseeable future. We
Bristol Myers (BMY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Bristol Myers Squibb (BMY) or Vertex Pharmaceuticals (VRTX). But which of these two stocks is
Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.
WATERTOWN, Mass., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Abata Therapeutics, a company focused on transforming lives with Treg therapies for severe autoimmune and inflammatory diseases, today announced it
Bristol Myers' (BMY) impressive second-quarter results propelled the stock in the past month. However, we advise investors not to be over-optimistic at this point and look before they leap.
The healthcare industry has been a critical part of the economy for a long time. According to a McKinsey & Company report, the healthcare industry is expected to grow at 7% from 2022 to 2027.
The concept of value stocks are easy to understand.

3 Stocks Retirees Should Absolutely Love

06:50am, Saturday, 10'th Aug 2024
AbbVie offers reliable income and solid growth prospects. Bristol Myers Squibb is a stable dividend stock to buy and hold.
Investing in biotech stocks with promising pipelines has to be the most exciting area of the market. A successful drug approval can not only unveil a blockbuster treatment worth billions of dollars, b
Bristol-Myers Squibb stock surged after surprisingly good Q2 2024 results, but it's unlikely that the rise can be sustained for now. The company's upgraded guidance is too small to improve prospects f
On July 26, Bristol-Myers Squibb pleasantly shocked Wall Street with its financial results for the second quarter of 2024. Thanks to strong sales of the company's oncology franchise, it raised its ful
The S&P 500 index came close to correction territory on Aug. 2, after falling about 5.7% from a peak it reached in mid-July. With drugs that some of us can't live without, Bristol Myers Squibb hasn't
24/7 Wall St. Insights With inflation starting to be tamed, dividend stocks will be in big demand as rates drop.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE